Conception, embryonic development and corpus luteum function in beef cattle open for two consecutive breeding seasons

1983 ◽  
Vol 20 (6) ◽  
pp. 627-637 ◽  
Author(s):  
S.E. Echternkamp ◽  
R.R. Maurer
2013 ◽  
Vol 38 (3) ◽  
pp. 300-304
Author(s):  
Wei-xin JIANG ◽  
You-sheng LIU ◽  
Li-qun XUE ◽  
Xiao-jun CHEN ◽  
Li-guo YANG ◽  
...  

2009 ◽  
Vol 81 (Suppl_1) ◽  
pp. 582-582 ◽  
Author(s):  
Dale E. Kelley ◽  
Chris J. Mortensen ◽  
Jillian L. Fain ◽  
John R. Gibbons
Keyword(s):  

2013 ◽  
Vol 25 (1) ◽  
pp. 237
Author(s):  
R. S. Ramos ◽  
F. S. Mesquita ◽  
G. Pugliesi ◽  
S. C. Scolari ◽  
M. L. Oliveira ◽  
...  

Recent evidence indicates that the progesterone (P4) secretion by corpus luteum (CL) during early diestrus is affected by the size of ovulatory follicle and has a significant impact on embryo development and conception rates. Therefore, strategies to promote the growth of the dominant follicle and/or to stimulate the early development of the CL to increase P4 secretion become an alternative to improve conception rates in the beef cattle industry. Our aim was to study the effect of manipulations of the follicle growth on the diameter of the preovulatory follicle (POF) and subsequent size and function of the CL. Cyclic and non-lactating Nelore cows, pre-synchronized by 2 injections of prostaglandin F2α (PGF) 14 d apart, were manipulated to ovulate large or small follicles according to 3 experiments. In Experiment 1 (Exp. 1; n = 23), animals received a second-use intravaginal P4-releasing device along with an injection of oestradiol benzoate on Day –10 (Day 0 = GnRH injection). Cows were split to receive (large follicle group; LF) or not (small follicle group; SF) a PGF injection on Day –10. Progesterone devices were removed on Day –2.5 in the LF group and on Day –1.5 in the SF group. The PGF was injected at the removal of the P4 device. In Experiment 2 (Exp. 2; n = 38), cows in the LF group had the P4 device removed on Day –2.25 or Day –2, whereas in Experiment 3 (Exp. 3; n = 23), the device (first-use) was removed on Day –1.75 in the LF group and on Day –1.25 in the SF group; the other manipulations were similar to Exp. 1. Data analyses were done only on cows that had a functional CL on Day –10 (P4 > 1 ng mL–1) and that ovulated within 24 and 48 h post-GnRH (Exp. 1, n = 14; Exp. 2, n = 14; Exp. 3, n = 12). The three experiments were successful in inducing POF with different sizes, as indicated by the greater diameter of the POF in the LF group compared with SF in Exp. 1 (12.9 ± 0.5 mm v. 10.7 ± 0.6 mm; P < 0.03), Exp. 2 (14.1 ± 0.6 mm v. 11.7 ± 0.4 mm; P < 0.006), and Exp. 3 (13.8 ± 0.6 mm v. 11.7 ± 0.8 mm; P < 0.06). To evaluate the effect of POF size on size and function of the CL, a factorial analysis was performed by SAS software to test the effect of group, day, and their interaction. For CL volume, an effect of group was detected in Exp. 1 (P < 0.02) and in Exp. 3 (P < 0.06), but not in Exp. 2. The group effect represented greater average CL volume from Day 3 to Day 7 in LF (2.42 ± 0.27 and 2.5 ± 0.39 cm3) than in the SF group (1.39 ± 0.18 and 1.2 ± 0.15 cm3) for Exp. 1 and 3, respectively. For P4 concentrations, a group effect was detected only in Exp. 3 (P < 0.007), as indicated by greater average P4 concentrations from Day 3 to Day 7 in LF (2.31 ± 0.31 ng mL–1) than in the SF group (1.37 ± 0.19 ng mL–1). A day effect was detected in all experiments (P < 0.0001), as indicated by a progressive increase of CL volume and P4 concentrations from Day 3 to Day 7. Manipulation of follicle growth performed in Exp. 3 was the most efficient to modify the function and size of the CL. In conclusion, control of POF size by manipulation of P4 concentrations during growth of the dominant follicle alters the size and function of CL postovulation. CNPq, FAPESP, Ourofino, and PUSP-P.


2012 ◽  
Vol 24 (1) ◽  
pp. 115
Author(s):  
C. A. Messerschmidt ◽  
F. M. Abreu ◽  
L. H. Cruppe ◽  
M. V. Biehl ◽  
M. L. Day ◽  
...  

The objective of this study was to determine the effects of meclofenamic acid, a nonsteroidal anti-inflammatory, on luteal function of beef cattle. A total of 18 Angus cows, aged between 2 and 3 years old, were enrolled in the experiment. All cows were synchronized using a 5-day CIDR protocol. Briefly, cows received 100 μg of gonadorelin diacetate tetrahydrate (GnRH; Cystorelin®, Merial, Athens, GA, USA) and a controlled internal drug release insert (CIDR; Eazi-BreedTM CIDR®, Pfizer Animal Health, New York, NY, USA). Five days later, the CIDR was removed and 50 mg of dinoprost (Lutalyse®, Pfizer Animal Health) was administered intramuscularly. Oestrus was determined by twice daily observations of mounting behaviour and tail painting scores (day of oestrus = Day 0). At 72 h after dinoprost, a second dose of gonadorelin (100 μg, IM) was administered. On Day 14, cows were randomly assigned to the following treatment groups: 1) control: 10 mL of saline solution administered IM; 2) systemic: 2 g of meclofenamic acid administered IM; and 3) oral: 2 g of meclofenamic acid administered orally. Cows were treated once daily for 11 days (i.e. until Day 24) and no adverse reactions were observed. Blood sampling and ovarian ultrasonography were performed every 72 h from Day 0 until Day 12 and then every 48 h until the end of the study. Serum progesterone concentrations were determined by radioimmunoassay and were used to determine functional luteolysis (i.e. progesterone <1 ng mL–1). Ovaries were evaluated for the presence of a corpus luteum and to evaluate follicular growth and subsequent ovulation. One-way ANOVA was used to compare the day of peak progesterone concentration, lifespan of the corpus luteum and the length of the oestrous cycle between groups. Significance was set at P < 0.05 and data are presented as means ± standard error of the mean (Table 1). There were no effects of meclofenamic acid administration on any of the parameters evaluated (P > 0.05). In conclusion, meclofenamic acid administration did not affect luteal function in our study. Potentially, higher doses of meclofenamic acid may be necessary to inhibit prostaglandin synthesis and prevent luteolysis. Table 1.Effects of meclofenamic acid administration on the day of peak progesterone concentration, lifespan of the corpus luteum (CL) and the length of oestrous cycle in beef cows (mean ± standard error of the mean) Funding was provided by The Ohio State University, College of Veterinary Medicine, USDA-Animal Health Formula Funds. The authors are also grateful to the staff at the OSU Beef Center Facility for helping with animal handling and care.


2021 ◽  
Vol 33 (2) ◽  
pp. 127
Author(s):  
J. F. Torres-Simental ◽  
S. Romo-Garcia ◽  
A. L. Munguia-Ramirez ◽  
P. Luna-Nevarez

The objective of the present study was to measure serum levels of obestatin by ELISA with the purpose of establishing parameters and being able to use it as an endocrine marker for the selection of reproductive characteristics of milk and beef cattle. In test 1, 15 Creole cows with genetic tendencies of Charolais, Angus, Brangus, and Gelbvieh were sampled in diestrus and 15 in proestrus, determining their structures with an Aloka Prosound ultrasound with a 7.5-MHz linear transducer. In test 2, 16 Holstein cows were sampled in 2 different ovarian stages, diestrus and proestrus. The standardized technique was a bovine obestatin 96-well ELISA kit from My Biosource Inc. The data were analysed by measuring central tendency and linear regression, where the average levels of obestatin were related to the corpus luteum size and size and number of follicles in milk and beef cattle. We found average levels of 556.99 and 453.35 pg for beef and dairy cattle, respectively (P&lt;0.05). We also found a significant difference (P&lt;0.05) in obestatin concentrations depending on the size of the follicles (751.74, 615.33, and 357.39 pg for follicles of 15, 10, and 5mm, respectively). We found a significant difference in concentration of obestatin (644.53, 550.69, and 455.88 pg; P&lt;0.05) for corpus luteum sizes of &gt;20mm, 10–20mm, and &lt;10mm, respectively. In dairy cattle, obestatin levels were also evaluated at different stages of the cycle, and we found concentrations of 414.79 pg in diestrus and 530.48 pg in proestrus (P&lt;0.05). We conclude that obestatin concentration is positively associated with a greater number and size of follicles as well as with larger corpus luteum because its effect on cell proliferation interacting positively with high levels of progesterone in the blood. We found higher concentrations in beef cattle than in dairy cattle.


1979 ◽  
Vol 27 (5) ◽  
pp. 901 ◽  
Author(s):  
G Shaw ◽  
RW Rose

The histological changes in the corpus luteum and uteri of P. tridactylus throughout delayed gestation are described. Early in gestation there appears to be a unilateral stimulus of the uterus ipsilateral to the corpus luteum. Late in gestation there appears to be a foeto-placental stimulus of the pregnant uterus. Embryonic development is closely associated with the uterine changes. At about day 29 after removal of pouch young the foetus is born via the median vagina. A model is proposed to explain the apparently great discrepancy between the length of delayed and undelayed gestation in this species.


1999 ◽  
Vol 1999 ◽  
pp. 64-64
Author(s):  
G.R. Starbuck ◽  
G.E. Mann ◽  
G.E. Lamming

Historically there has been some controversy over possible detrimental effects of exogenous prostaglandin F? ? ? (PGF? ?) administration on the function of the subsequent corpus luteum (CL). In the light of recent evidence that early luteal phase progesterone is essential for embryonic development (Mann et al., 1996) combined with the clinical use of PGF2? analogues in herd fertility management, an urgent need has arisen for this matter to be clarified. This abstract presents work designed to investigate whether two of the commercially available PGF? ? analogues used in veterinary therapy have any detrimental effect on corpus luteum function.


Author(s):  
Nkadimeng Marble ◽  
van Marle-Köster ◽  
Lekola Kgomotso ◽  
Mphaphathi Masindi Lotus ◽  
Lehloenya Khoboso Christina ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document